Docquity

Accessible medical education empowers healthcare professionals (HCPs) to deliver better care. Preventive medicine knowledge, in particular, equips HCPs to tackle potential health crises. 🩺 🇻🇳 That’s why we’re kicking off 2025 with a new partnership with the Ho Chi Minh City Center for Disease Control (HCDC) to launch an educational channel on the Docquity platform. This multi-year initiative will connect over 3,000 HCPs across Vietnam with the latest advancements in disease prevention. Together, we’re building a stronger network dedicated to improving patient outcomes. Here’s to a new year of innovation, collaboration, and healthier futures for all. 🌟 #NewPartnership #PreventiveMedicine #MedicalEducation #Docquity #Vietnam 

Kicking off our partnership with Solé Pharma in the Philippines 🇵🇭 with an immersive three-day product training on their wellness supplements and expertise. Sole Pharma will leverage Docquity's leading network of healthcare professionals (HCPs) to provide Filipino doctors with deeper medical insights and education on the latest in supplement innovation. Working with local distributors and partners, we aim to increase awareness around and access to preventative health products across the Philippines, reaching both HCPs and consumers. This training marked an important beginning, with in-depth knowledge sharing on Sole Pharma's mission and goals. We look forward to supporting the growth of a healthier community in the Philippines. 🌱💊 #Docquity #SolePharma #HealthcareInnovation #WellnessSupplements #PreventativeHealth #MedicalEducation #PhilippinesHealthcare #HealthierCommunity

Unveiling the third instalment of Docquity Pulse Check 2024! We surveyed 900+ Southeast Asian doctors to understand what they want from pharma companies. Our findings highlight the importance of relationships and scientific credibility. Here’s a quick guide for med reps: 1️⃣ 86.7% of doctors value relationships with pharma reps.   2️⃣ 70%+ like regular (weekly or monthly) updates – keeping information fresh and relevant. Their primary channels? Digital media, in-person meetings, and messaging apps.  3️⃣ 91.6% of doctors opt for focused discussions on just 1-3 products at once.  4️⃣ Scientific content is the most significant factor influencing prescription decisions for 83.7% of doctors. 72.1% rely on evidence-based resources the most for learning about pharma products.  5️⃣ 98.6% of doctors view pharma-sponsored Continuing Medical Education (CME) events as vital for their learning.     🚀 Learn more from our blog linked below.     #DocquityPulseCheck #DocquityPulseCheck2024 #PharmaMarketing #HealthcareProfessionals #HCPInsights #HCPEngagement #SoutheastAsia

Docquity was thrilled to be part of PEXLIFT Asia 2024 last month! The event brought together the entire healthcare ecosystem, creating a vibrant space for knowledge exchange with pharmaceutical leaders, medical associations and healthcare professionals (HCPs). Our team showcased the power of micro-moments in HCP education, sparking valuable conversations on the future of digital in healthcare. We came away with fresh perspectives on industry challenges and look forward to transforming these learnings into even greater value for our clients and users. Together, let's drive impactful change in healthcare. #PEXLIFTASIA2024 #PharmaConference #HealthcareInnovation Dhruv Singh Subashini Indrasanan Rish Gill SheJui Fung Keng Yean Tan

🌟 It’s truly inspiring to collaborate with AstraZeneca and key medical associations in Thailand to advance education on Non-communicable Diseases (NCDs). This certification program for Healthcare Professionals (HCPs) showcases the power of industry partnerships in addressing public health challenges. As the official training platform for this initiative, Docquity will equip Thai HCPs with the latest medical knowledge on NCDs and related treatments. 💡🩺 This CSR effort by Docquity will provide doctors with complimentary training to significantly enhance patient care for NCDs across the country. 🇹🇭❤️ Together, we’re driving meaningful improvements in healthcare and building healthier communities in Thailand. 🌍🤝 #CSR #NCDs #HealthcareEducation #Docquity #HCPTraining #CollaborationForImpact

As the medical landscape constantly evolves, it is crucial for healthcare professionals (HCPs) to access the latest clinical evidence and advancements to provide the best care for their patients. 📚🩺 💡 In a recent interview with NutraIngredients Asia, Christophe Meugnier, Docquity’s Chief Commercial Officer, highlighted how our Awareness to Advocacy (A2A) Program helps pharmaceutical companies such as Laboratorio Farmaceutico SIT equip target HCPs with the latest medical knowledge to improve healthcare decision-making. Doctors in Thailand originally had limited knowledge around the efficacy and quality of different probiotics. Docquity’s A2A Program has enhanced SIT Pharma’s efforts to engage more doctors through education, ensuring more patients can benefit from probiotics as part of their treatment plans. 🏥👩⚕️👨⚕️ #MedicalEducation #HealthcareInnovation #PharmaCompanies #HCPs #PatientCare 

At the recent Reuters Events Pharma in Japan, Docquity's Chief Commercial Officer, Christophe Meugnier discussed how leading healthcare enterprises can adapt to the evolving landscape of doctor-pharma engagements and drive stronger business results. While traditional face-to-face meetings with medical representatives have served the industry for years, they are no longer sufficient to reach and understand today's digitally savvy healthcare professionals (HCPs). Docquity, Southeast Asia's largest verified HCP community, leverages its in-depth network insights to empower pharma companies with high quality, unbiased, and actionable data and insights. Our knowledge on HCP behavior, combined with advanced AI/ML technologies, enables us to provide a 360° view of HCP preferences, connect with them through targeted and personalized interactions, and measure the impact of campaigns, including brand perception and intent to prescribe. We've brought home the learnings from conversations with healthcare stakeholders we met at Reuters Pharma Japan 2024 to continue developing innovative products and services that cultivate meaningful doctor-pharma engagements and transform healthcare interactions. #HCPInsights #REPharmaJP #PharmaConference 

Docquity is honored to be part of the Tokyo Stock Exchange (TSE) Asia Startup Hub initiative! 🌏🚀 As one of the innovative Asian startups in this ecosystem, the program will help us forge stronger connections in Japan, opening doors to more partnerships with leading Japanese firms. We're committed to leveraging our healthcare data science expertise to support more healthcare practitioners and enterprises in solving challenges and improving patient outcomes across the region. 🩺💡 For more about the TSE Asia Startup Hub: https://lnkd.in/gT6wmZm9 #TSE #Japan #startup #healthtech #innovation

The second edition of Docquity Pulse Check 2024 is live! We surveyed 460 Southeast Asian doctors on their learning preferences and the results are clear: a blend of digital and in-person learning is the norm. Key findings:  📊 81.5% of doctors attend both digital and in-person learning events, with more frequent digital participation  💻 67.6% prefer digital attendance at hybrid events  📱 91.3% access on-demand digital content for its convenience  🔍 Top learning channels: medical apps, search engines and peer support    As Southeast Asia’s largest network of healthcare professionals, we’re excited to share these insights and help shape the future of medical education. 🎓    📖 Discover more in our blog and infographic linked below.   #DocquityPulseCheck #DocquityPulseCheck2024 #MedicalEducation #DigitalLearning #HealthcareInnovation #SoutheastAsia 

Counting down to Reuters Events Pharma in Japan in a few weeks. Docquity will host an exhibition booth with exciting demos of our technology and our Chief Commercial Officer, Christophe Meugnier will address the audience on innovative strategies for forming deeper engagements with healthcare professionals (HCPs). To our industry peers, partners and network based in Japan, we look forward to seeing you there! #REPharmaJP #PharmaConference #HCPengagement